HEALTH● LOWAug 20 · Aug 20, 2026, 1:00 PM
Nuvation granted Fast Track status for safusidenib for brain tumors
Seeking Alpha Tech
Nuvation has received Fast Track status for safusidenib, a potential treatment for brain tumors. This status aims to expedite the development and review of drugs for serious conditions.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH34m agoBiohaven surges as FDA accepts resubmission for Vyglxia for spinocerebellar ataxiaSeeking Alpha TechHEALTH44m agoEbola: Africa CDC urges African ownership, accountability in outbreak responsePremium TimesHEALTH44m agoScrewworm spreads to US wildlife in Texas, USDA saysThe HillHEALTH47m agoFirst known human case of Shamonda virus confirmed in FrancePolitico Europe